INCUINTA and Bioinnovo apply their knowledge to fight COVID19

Argentine researchers used two different platforms to neutralize the virus with “nanobodies” derived from llamas [...]

Bioinnovo will increase production of the vaccine against Bovine Viral Diarrhea Virus

Bioinnovo, a public-private partnership between INTA and Vetanco S.A., will allocate an important support, granted by the Ministry [...]

A new achievement in the fight against COVID-19

A multidisciplinary team, where Bioinnovo SA participates, developed IgY avian antibodies that neutralize the COVID-19 [...]

Vetanco and Bioinnovo congratulate the company Algenex on a new achievement

Algenex, the Spanish company delivering recombinant technologies, a key factor for the development of Vedevax BLOCK, [...]

Bovine Viral Diarrhea: the Argentinian vaccine will be sold in Peru

The Andean Country authorized the commercialization of Vedevax Block, the first recombinant vaccine for the control [...]

100% Argentinian technology for the COVID-19 test

Specialists of the National Institute of Industrial Technology (INTI) and the national company Ivema Desarrollos designed an [...]

Vetanco develops an alliance with the UDESC

The constant Research and Development is a principle of Vetanco DNA and the reason why [...]

Sherry Layton, Vetanco USA Inc. CSO, was invited to give a presentation at Vaccines 2020

Due to the rising interest in Biotech Vac. Technology, Sherry Layton, Chief Scientific Officer of [...]

Pig farming situation in the USA

What follows is a general outlook of the reality that pig farming in the United [...]

Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis

Bioinnovo, the public-private company (INTA–Vetanco) made its first contribution to the macro collaborative project conducted [...]